查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1314779

脊椎生物製品市場：副產品（移植骨替代物、細胞基質、同種異體脊椎移植物），依最終使用者（門診手術中心、醫院）-2023-2030 年全球預測

Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), End-User (Ambulatory Surgical Centers, Hospitals) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球脊椎生物製劑市場將大幅成長，達50.9374億美元，年複合成長率為17.08%，2030年將達到153.804億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球脊椎生物製劑市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 脊椎生物製劑的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球脊椎生物製品市場的阻礙因素和影響為何？

3. 在預測期內，全球脊椎生物製品市場需要投資哪些產品/細分市場/應用/領域？

4.全球脊椎生物製劑市場的競爭策略是什麼？

5. 全球脊椎生物製劑市場的技術趨勢和法律規範是什麼？

6. 全球脊椎生物製劑市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球脊椎生物製劑市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 對微創手術的需求和偏好不斷成長
      • 脊髓退化疾病的發生率和治療率不斷增加
      • 骨移植手術的快速進展
    • 抑制因素
      • 這些程序非常昂貴
    • 機會
      • 生物材料的持續進步改善脊椎疾病的治療
      • 政府資助擴大脊椎生物學研究
    • 任務
      • 產品召回問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 脊椎生物製劑市場：副產品

  • 骨移植替代物
    • 骨形成蛋白
    • 合成骨移植物
  • 基於細胞的矩陣
  • 同種異體脊椎移植物
    • 去礦骨基質
    • 機械加工同種異體骨

第7章 脊椎生物製品市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第8章 美洲脊椎生物製品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太脊椎生物製品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲脊椎生物製品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-A86604082636

The Global Spine Biologics Market is forecasted to grow significantly, with a projected USD 5,093.74 million in 2023 at a CAGR of 17.08% and expected to reach a staggering USD 15,380.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Spine Biologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Spine Biologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Bone Graft Substitutes, Cell-Base Matrix, and Spinal Allografts. The Bone Graft Substitutes is further studied across Bone Morphogenetic Proteins and Synthetic Bone Grafts. The Spinal Allografts is further studied across Demineralized Bone Matrix and Machined Bones Allograft. The Bone Graft Substitutes is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Spine Biologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Spine Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spine Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spine Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Spine Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Spine Biologics Market?

6. What is the market share of the leading vendors in the Global Spine Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Spine Biologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Spine Biologics Market, by Product, 2022 vs 2030
  • 4.3. Spine Biologics Market, by End-User, 2022 vs 2030
  • 4.4. Spine Biologics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand and preference for minimally invasive procedures
      • 5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
      • 5.1.1.3. Proliferation in advancements of bone grafting procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Extremely high cost of these procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine disorders
      • 5.1.3.2. Government funding to expand spine biologics research
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Spine Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Bone Graft Substitutes
    • 6.2.1. Bone Morphogenetic Proteins
    • 6.2.2. Synthetic Bone Grafts
  • 6.3. Cell-Base Matrix
  • 6.4. Spinal Allografts
    • 6.4.1. Demineralized Bone Matrix
    • 6.4.2. Machined Bones Allograft

7. Spine Biologics Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Spine Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Spine Biologics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Spine Biologics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. SPINE BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINE BIOLOGICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. SPINE BIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. SPINE BIOLOGICS MARKET DYNAMICS
  • FIGURE 8. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 6. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 11. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. GERMANY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ITALY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NORWAY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. POLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. QATAR SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SPAIN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. TURKEY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 186. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 187. SPINE BIOLOGICS MARKET LICENSE & PRICING